Literature DB >> 18985421

Complementary and alternative medicines in ankylosing spondylitis: a cross-sectional study.

Simon M Chatfield1, Shyamali C Dharmage, Anthony Boers, Belinda J Martin, Russell R C Buchanan, Walter P Maksymowych, Lionel Schachna.   

Abstract

Prevalence of dietary complementary and alternative medicine (CAM) and consultation with a CAM practitioner was examined in a cross-sectional study of 75 AS patients. Seventy one of 75 (94.7%) study participants reported previous or current CAM use. Among these AS patients, 44 (72.1%) reported dietary CAM use and 27 (36.0%) were seeing a CAM practitioner at the time of study. Of 89 dietary CAM, 50 (56.4%) were perceived to be of slight or no benefit, and only 10 (11.2%) were initiated by a CAM practitioner. Compared with non-users, current dietary CAM users were more likely to be female (OR 6.5; 95% CI, 1.8-23.9). Patients attending a CAM practitioner were more likely to have university education (OR 5.7; 95% CI, 1.5-21.9) and higher BASDAI (OR 1.3; 95%CI, 1.0-1.7). Despite low rates of perceived benefit, dietary CAM use and CAM practitioner attendance is common among AS patients.

Entities:  

Mesh:

Year:  2008        PMID: 18985421     DOI: 10.1007/s10067-008-1029-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Prevalence of the use of unconventional remedies for arthritis in a metropolitan community.

Authors:  T A Cronan; R M Kaplan; L Posner; E Blumberg; F Kozin
Journal:  Arthritis Rheum       Date:  1989-12

3.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Assessment of health locus of control in the use of nonconventional remedies by patients with rheumatic diseases.

Authors:  C Ramos-Remus; C A Watters; L Dyke; M E Suarez-Almazor; A S Russell
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

Review 6.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  Diet and disease symptoms in rheumatic diseases--results of a questionnaire based survey.

Authors:  M Haugen; J Kjeldsen-Kragh; B Y Nordvåg; O Førre
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

9.  Attitudes to alternative medicine by rheumatology outpatient attenders.

Authors:  P C Vecchio
Journal:  J Rheumatol       Date:  1994-01       Impact factor: 4.666

10.  Prevalence and cost of alternative medicine in Australia.

Authors:  A H MacLennan; D H Wilson; A W Taylor
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

View more
  7 in total

Review 1.  Rheumatologists' opinions towards complementary and alternative medicine: a systematic review.

Authors:  Rebecca Grainger; Jennifer Walker
Journal:  Clin Rheumatol       Date:  2013-08-30       Impact factor: 2.980

Review 2.  Relationship between diet and ankylosing spondylitis: A systematic review.

Authors:  Tatiana V Macfarlane; Hadeel M Abbood; Ejaz Pathan; Katy Gordon; Juliane Hinz; Gary J Macfarlane
Journal:  Eur J Rheumatol       Date:  2017-10-25

3.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].

Authors:  U Kiltz; J Sieper; H Kellner; D Krause; M Rudwaleit; J-F Chenot; A Stallmach; S Jaresch; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

4.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

5.  A retrospective study of transcutaneous electrical nerve stimulation for chronic pain following ankylosing spondylitis.

Authors:  Fu-Chun Chen; Zhen-Ling Jin; Deng-Feng Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

6.  Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis.

Authors:  Ashley Fletcher; Marissa Lassere; Lyn March; Catherine Hill; Graeme Carroll; Claire Barrett; Rachelle Buchbinder
Journal:  Int J Rheumatol       Date:  2020-06-05

Review 7.  Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use.

Authors:  Rebecca Reid; Amie Steel; Jon Wardle; Andrea Trubody; Jon Adams
Journal:  BMC Complement Altern Med       Date:  2016-06-11       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.